Aerosol Drug Delivery During Noninvasive Positive Pressure Ventilation: Effects of Intersubject Variability and Excipient Enhanced Growth

J Aerosol Med Pulm Drug Deliv. 2017 Jun;30(3):190-205. doi: 10.1089/jamp.2016.1343. Epub 2017 Jan 11.

Abstract

Background: Nebulized aerosol drug delivery during the administration of noninvasive positive pressure ventilation (NPPV) is commonly implemented. While studies have shown improved patient outcomes for this therapeutic approach, aerosol delivery efficiency is reported to be low with high variability in lung-deposited dose. Excipient enhanced growth (EEG) aerosol delivery is a newly proposed technique that may improve drug delivery efficiency and reduce intersubject aerosol delivery variability when coupled with NPPV.

Materials and methods: A combined approach using in vitro experiments and computational fluid dynamics (CFD) was used to characterize aerosol delivery efficiency during NPPV in two new nasal cavity models that include face mask interfaces. Mesh nebulizer and in-line dry powder inhaler (DPI) sources of conventional and EEG aerosols were both considered.

Results: Based on validated steady-state CFD predictions, EEG aerosol delivery improved lung penetration fraction (PF) values by factors ranging from 1.3 to 6.4 compared with conventional-sized aerosols. Furthermore, intersubject variability in lung PF was very high for conventional aerosol sizes (relative differences between subjects in the range of 54.5%-134.3%) and was reduced by an order of magnitude with the EEG approach (relative differences between subjects in the range of 5.5%-17.4%). Realistic in vitro experiments of cyclic NPPV demonstrated similar trends in lung delivery to those observed with the steady-state simulations, but with lower lung delivery efficiencies. Reaching the lung delivery efficiencies reported with the steady-state simulations of 80%-90% will require synchronization of aerosol administration during inspiration and reducing the size of the EEG aerosol delivery unit.

Conclusions: The EEG approach enabled high-efficiency lung delivery of aerosols administered during NPPV and reduced intersubject aerosol delivery variability by an order of magnitude. Use of an in-line DPI device that connects to the NPPV mask appears to be a convenient method to rapidly administer an EEG aerosol and synchronize the delivery with inspiration.

Keywords: computational fluid dynamics; excipient enhanced growth; inline dry powder inhaler; nebulized aerosol; noninvasive positive pressure ventilation.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aerosols
  • Drug Delivery Systems*
  • Dry Powder Inhalers
  • Excipients / chemistry*
  • Female
  • Humans
  • Hydrodynamics
  • Lung / metabolism*
  • Masks
  • Models, Anatomic
  • Nasal Cavity / anatomy & histology
  • Nebulizers and Vaporizers
  • Noninvasive Ventilation / methods
  • Positive-Pressure Respiration*
  • Young Adult

Substances

  • Aerosols
  • Excipients